Daniel J Deer
Overview
Explore the profile of Daniel J Deer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
1059
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Prasad A, Agans K, Geisbert J, Borisevich V, Deer D, Dobias N, et al.
J Infect Dis
. 2023 Jun;
228(Suppl 7):S571-S581.
PMID: 37348509
Background: The primary route of infection by Ebola virus (EBOV) is through contact of mucosal surfaces. Few studies have explored infection of nonhuman primates (NHPs) via the oral mucosa, which...
12.
Woolsey C, Strampe J, Fenton K, Agans K, Martinez J, Borisevich V, et al.
J Infect Dis
. 2023 Jun;
228(Suppl 7):S712-S720.
PMID: 37290053
Background: The filovirus Bundibugyo virus (BDBV) causes severe disease with a mortality rate of approximately 20%-51%. The only licensed filovirus vaccine in the United States, Ervebo, consists of a recombinant...
13.
Woolsey C, Borisevich V, Agans K, OToole R, Fenton K, Harrison M, et al.
J Infect Dis
. 2023 May;
228(Suppl 7):S660-S670.
PMID: 37171813
Background: The family Filoviridae consists of several virus members known to cause significant mortality and disease in humans. Among these, Ebola virus (EBOV), Marburg virus (MARV), Sudan virus (SUDV), and...
14.
Prasad A, Fenton K, Agans K, Borisevich V, Woolsey C, Comer J, et al.
J Infect Dis
. 2023 May;
228(Suppl 7):S604-S616.
PMID: 37145930
Background: Highly pathogenic filoviruses such as Ebola virus (EBOV) hold capacity for delivery by artificial aerosols, and thus potential for intentional misuse. Previous studies have shown that high doses of...
15.
Cross R, Prasad A, Woolsey C, Agans K, Borisevich V, Dobias N, et al.
Sci Rep
. 2023 Mar;
13(1):4175.
PMID: 36914721
Transmission of Ebola virus (EBOV) primarily occurs via contact exposure of mucosal surfaces with infected body fluids. Historically, nonhuman primate (NHP) challenge studies have employed intramuscular (i.m.) or small particle...
16.
Woolsey C, Borisevich V, Fears A, Agans K, Deer D, Prasad A, et al.
J Clin Invest
. 2022 Nov;
133(3).
PMID: 36445779
The emergence of the novel henipavirus, Langya virus, received global attention after the virus sickened over three dozen people in China. There is heightened concern that henipaviruses, as respiratory pathogens,...
17.
Cross R, Woolsey C, Prasad A, Borisevich V, Agans K, Deer D, et al.
Cell Rep
. 2022 Jul;
40(3):111094.
PMID: 35858566
Lassa virus (LASV) is recognized by the World Health Organization as one of the top five pathogens likely to cause a severe outbreak. A recent unprecedented resurgence of LASV in...
18.
Kuang E, Cross R, McCavitt-Malvido M, Abelson D, Borisevich V, Stuart L, et al.
Pathogens
. 2022 Jun;
11(6).
PMID: 35745509
Intravenous (IV) administration of antiviral monoclonal antibodies (mAbs) can be challenging, particularly during an ongoing epidemic, due to the considerable resources required for performing infusions. An ebolavirus therapeutic administered via...
19.
Woolsey C, Fears A, Borisevich V, Agans K, Dobias N, Prasad A, et al.
Emerg Microbes Infect
. 2022 Jun;
11(1):1635-1646.
PMID: 35657325
Due to its high mortality rate and continued re-emergence, Ebolavirus disease (EVD) continues to pose a serious threat to global health. A group of viruses within the genus causes this...
20.
Woolsey C, Cross R, Agans K, Borisevich V, Deer D, Geisbert J, et al.
PLoS Negl Trop Dis
. 2022 May;
16(5):e0010433.
PMID: 35622847
Background: Marburg virus (MARV), an Ebola-like virus, remains an eminent threat to public health as demonstrated by its high associated mortality rate (23-90%) and recent emergence in West Africa for...